PMC:2944646 / 26972-27673 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/2944646","sourcedb":"PMC","sourceid":"2944646","source_url":"https://www.ncbi.nlm.nih.gov/pmc/2944646","text":"Figure 4 Piracetam improves neuritogenesis following Aß exposure. (A) PC12 cells were treated over 6 days with NGF 50 ng/ml in the presence of oligomeric Aβ 1 μM. Piracetam 1 mM was added and the effects on neurite outgrowth were investigated. (B) APPsw PC12 cells were treated over 6 days with NGF 50 ng/ml in the presence or absence of piracetam 1 mM and neurite outgrowth was measured. In the presence of different NGF concentrations (1–50 ng/ml) piracetam improved the neurotrophic effect of NGF in APPsw cells. All data are modified after Kurz et al. (2010). Data are expressed as mean ± SEM (n = 6–7) **p \u003c 0.01, ***p \u003c 0.001 vs. the respective control, two-way anova with bonferroni post test.","divisions":[{"label":"label","span":{"begin":0,"end":8}}],"tracks":[{"project":"TEST0","denotations":[{"id":"20877425-41-49-198963","span":{"begin":558,"end":562},"obj":"[\"20218980\"]"}],"attributes":[{"subj":"20877425-41-49-198963","pred":"source","obj":"TEST0"}]},{"project":"0_colil","denotations":[{"id":"20877425-20218980-198963","span":{"begin":558,"end":562},"obj":"20218980"}],"attributes":[{"subj":"20877425-20218980-198963","pred":"source","obj":"0_colil"}]},{"project":"2_test","denotations":[{"id":"20877425-20218980-38148056","span":{"begin":558,"end":562},"obj":"20218980"}],"attributes":[{"subj":"20877425-20218980-38148056","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"TEST0","color":"#b093ec","default":true},{"id":"0_colil","color":"#93ec96"},{"id":"2_test","color":"#ec93a9"}]}]}}